224
Views
15
CrossRef citations to date
0
Altmetric
Research Article

Development of amitriptyline buccoadhesive tablets for management of pain in dental procedures

, , , , , , & show all
Pages 849-854 | Received 14 Jul 2010, Accepted 03 Dec 2010, Published online: 14 Jan 2011

References

  • Burch JE, Ahmed O, Hullin RP, Mindham RH. (1988). Antidepressive effect of amitriptyline treatment with plasma drug levels controlled within three different ranges. Psychopharmacology (Berl), 94:197–205.
  • Matthews K, Eagles JM, Matthews CA. (1993). The use of antidepressant drugs in general practice. A questionnaire survey. Eur J Clin Pharmacol, 45:205–210.
  • Goldman RH, Stason WB, Park SK, Kim R, Mudgal S, Davis RB, Kaptchuk TJ. (2010). Low-dose amitriptyline for treatment of persistent arm pain due to repetitive use. Pain, 149:117–123.
  • Khan OA, Majumdar S, Jones NS. (2002). Facial pain following sinonasal surgery or facial trauma. Clin Otolaryngol Allied Sci, 27:171–174.
  • Laird B, Colvin L, Fallon M. (2008). Management of cancer pain: basic principles and neuropathic cancer pain. Eur J Cancer, 44:1078–1082.
  • McQuay HJ, Carroll D, Glynn CJ. (1993). Dose–response for analgesic effect of amitriptyline in chronic pain. Anaesthesia, 48:281–285.
  • McQuay HJ, Carroll D, Glynn CJ. (1992). Low dose amitriptyline in the treatment of chronic pain. Anaesthesia, 47:646–652.
  • Fridrich P, Colvin HP, Zizza A, Wasan AD, Lukanich J, Lirk P, Saria A, Zernig G, Hamp T, Gerner P. (2007). Phase 1A safety assessment of intravenous amitriptyline. J Pain, 8:549–555.
  • Khan MA, Gerner P, Kuo Wang G. (2002). Amitriptyline for prolonged cutaneous analgesia in the rat. Anesthesiology, 96:109–116.
  • Gerner P, Mujtaba M, Sinnott CJ, Wang GK. (2001). Amitriptyline versus bupivacaine in rat sciatic nerve blockade. Anesthesiology, 94:661–667.
  • Güler N, Durmus E, Tuncer S. (2005). Long-term follow-up of patients with atypical facial pain treated with amitriptyline. N Y State Dent J, 71:38–42.
  • Agarwal V, Mishra B. (1999). Design, development, and biopharmaceutical properties of buccoadhesive compacts of pentazocine. Drug Dev Ind Pharm, 25:701–709.
  • Harris D, Robinson JR. (1992). Drug delivery via the mucous membranes of the oral cavity. J Pharm Sci, 81:1–10.
  • Hosny EA, Elkheshen SA, Saleh SI. (2002). Buccoadhesive tablets for insulin delivery: in-vitro and in-vivo studies. Boll Chim Farm, 141:210–217.
  • Nafee NA, Ismail FA, Boraie NA, Mortada LM. (2003). Mucoadhesive buccal patches of miconazole nitrate: in vitro/in vivo performance and effect of ageing. Int J Pharm, 264:1–14.
  • Nafee NA, Ismail FA, Boraie NA, Mortada LM. (2004). Mucoadhesive delivery systems. II. Formulation and in-vitro/in-vivo evaluation of buccal mucoadhesive tablets containing water-soluble drugs. Drug Dev Ind Pharm, 30:995–1004.
  • Nafee NA, Ismail FA, Boraie NA, Mortada LM. (2004). Mucoadhesive delivery systems. I. Evaluation of mucoadhesive polymers for buccal tablet formulation. Drug Dev Ind Pharm, 30:985–993.
  • Philip AK, Srivastava M, Pathak K. (2009). Buccoadhesive gels of glibenclamide: a means for achieving enhanced bioavailability. Drug Deliv, 16:405–415.
  • Rojanasakul Y, Wang LY, Bhat M, Glover DD, Malanga CJ, Ma JK. (1992). The transport barrier of epithelia: a comparative study on membrane permeability and charge selectivity in the rabbit. Pharm Res, 9:1029–1034.
  • Salamat-Miller N, Chittchang M, Johnston TP. (2005). The use of mucoadhesive polymers in buccal drug delivery. Adv Drug Deliv Rev, 57:1666–1691.
  • Yamsani VV, Gannu R, Kolli C, Rao ME, Yamsani MR. (2007). Development and in vitro evaluation of buccoadhesive carvedilol tablets. Acta Pharm, 57:185–197.
  • Alsarra IA, Alanazi FK, Mahrous GM, Abdel Rahman AA, Al Hezaimi KA. (2007). Clinical evaluation of novel buccoadhesive film containing ketorolac in dental and post-oral surgery pain management. Pharmazie, 62:773–778.
  • Hao J, Heng PW. (2003). Buccal delivery systems. Drug Dev Ind Pharm, 29:821–832.
  • Chary RB, Vani G, Rao YM. (1999). In vitro and in vivo adhesion testing of mucoadhesive drug delivery systems. Drug Dev Ind Pharm, 25:685–690.
  • Ikinci G, Capan Y, Senel S, Alaaddinoglu E, Dalkara T, Hincal AA. (2000). In vitro/in vivo studies on a buccal bioadhesive tablet formulation of carbamazepine. Pharmazie, 55:762–765.
  • Parodi B, Russo E, Gatti P, Cafaggi S, Bignardi G. (1999). Development and in vitro evaluation of buccoadhesive tablets using a new model substrate for bioadhesion measures: the eggshell membrane. Drug Dev Ind Pharm, 25:289–295.
  • Williams RO 3rd, Sykora MA, Mahaguna V. (2001). Method to recover a lipophilic drug from hydroxypropyl methylcellulose matrix tablets. AAPS Pharmscitech, 2:E8.
  • Wu B, Chen Z, Wei X, Sun N, Lu Y, Wu W. (2007). Biphasic release of indomethacin from HPMC/pectin/calcium matrix tablet: I. Characterization and mechanistic study. Eur J Pharm Biopharm, 67:707–714.
  • Emami J, Varshosaz J, Saljoughain N. (2008). Development and evaluation of controlled-release buccoadhesive verapamil hydrochloride tablets. Daru, 16:60–69.
  • Dortunç B, Ozer L, Uyanik N. (1998). Development and in vitro evaluation of a buccoadhesive pindolol tablet formulation. Drug Dev Ind Pharm, 24:281–288.
  • Mohammadi-Samani S, Bahri-Najafi R, Yousefi G. (2005). Formulation and in vitro evaluation of prednisolone buccoadhesive tablets. Farmaco, 60:339–344.
  • Bhat SR, Shivakumar HG. (2010). Bioadhesive controlled release clotrimazole vaginal tablets. Trop J Pharm Res, 9:339–346.
  • Khan KA. (1975). The concept of dissolution efficiency. J Pharm Pharmacol, 27:48–49.
  • Sator-Katzenschlager SM, Scharbert G, Kress HG, Frickey N, Ellend A, Gleiss A, Kozek-Langenecker SA. (2005). Chronic pelvic pain treated with gabapentin and amitriptyline: a randomized controlled pilot study. Wien Klin Wochenschr, 117:761–768.
  • Ghafourian T, Gafourian T, Safari A, Adibkia K, Parviz F, Nokhodchi A. (2007). A drug release study from hydroxypropylmethylcellulose (HPMC) matrices using QSPR modeling. J Pharm Sci, 96:3334–3351.
  • Shayeda GR, Palem CR, Rao YM. (2009). Development of novel bioadhesive buccal formulation of diltiazem: in vitro and in vivo characterization. PDA J Pharm Sci Technol, 63:401–408.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.